Literature DB >> 30635204

Clinical and microbiological characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae in adult patients in Mexico.

Gabriela Echaniz-Aviles1, Elvira Garza-González2, Alma Lucía Román-Mancha3, Rayo Morfín-Otero4, Eduardo Rodríguez-Noriega4, Juan Jacobo Ayala-Gaytán5, Claudia Elena Guajardo-Lara5, Araceli Soto-Nogueron1, Maria Noemí Carnalla-Barajas1, Adrián Camacho-Ortiz6.   

Abstract

The aim of this study was to assess the risk factors and clinical and microbiological characteristics of community-acquired pneumonia (CAP) in adult patients in Mexico. Streptococcus pneumoniae classified as the causative agent of CAP in adult patients and patients with invasive S. pneumoniae isolates presented to three tertiary teaching hospitals during the 15-year study period were selected. Serotyping and susceptibility testing were performed for all included isolates. Clinical and demographic data were recorded. A total of 96 patients infected with S. pneumoniae (71 with CAP, 25 with invasive disease) were included. The CAP group involved more males (74.6%) than the invasive disease group (p=0.03). Head trauma was more common in the CAP group (21.1%) than in the invasive disease group (4.0%; p=0.03). The most prevalent serotype was 19A, followed by serotypes 3 and 23F. After the introduction of the heptavalent conjugated pneumococcal vaccine (PCV7), the prevalence of included serotypes declined significantly; no such change was found after the introduction of the PCV13 vaccine, including in the prevalence of serotype 19A. Susceptibility to all antimicrobials tested except vancomycin declined over the study period. In conclusion, head trauma was the most common comorbidity in the CAP group. The most prevalent serotype was 19A. Decreased susceptibility to most antimicrobials tested was observed.
Copyright © 2018. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  Antimicrobial resistance; Resistencia antimicrobiana; Serotipo; Serotype; Streptococcus pneumoniae; Vaccine; Vacuna

Mesh:

Substances:

Year:  2019        PMID: 30635204     DOI: 10.1016/j.ram.2018.10.002

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  3 in total

1.  Laboratory-based surveillance in Latin America: attributes and limitations in evaluation of pneumococcal vaccine impact.

Authors:  Javier Nieto Guevara; Adriana Guzman-Holst
Journal:  Hum Vaccin Immunother       Date:  2021-10-07       Impact factor: 3.452

2.  Etiology and efficacy of anti-microbial treatment for community-acquired pneumonia in adults requiring hospital admission in Ukraine.

Authors:  Igor Kaidashev; Anna Lavrenko; Tatiana Baranovskaya; Victor Blazhko; Nataliia Digtiar; Oleksandr Dziublyk; Nataliia Gerasymenko; Liudmyla Iashyna; Volodymyr Kryvetskyi; Lesya Kuryk; Victoria Rodionova; Roman Stets; Ivan Vyshnyvetskyy; Yurii Feshchenko
Journal:  Acta Biomed       Date:  2022-05-11

3.  Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.

Authors:  Hector F Africano; Cristian C Serrano-Mayorga; Paula C Ramirez-Valbuena; Ingrid G Bustos; Alirio Bastidas; Hernan A Vargas; Sandra Gómez; Alejandro Rodriguez; Carlos J Orihuela; Luis F Reyes
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.